Role of complete lymphadenectomy in endometrioid uterine cancer

Lancet Oncology

Volumn 8, Issue 9, 2007, Pages 831-841

  Chan, John K ^a   Kapp, Daniel S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ACCURACY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CYSTIC LYMPHANGIOMA; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; EUROPE; EVIDENCE BASED MEDICINE; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; INTRAOPERATIVE PERIOD; JAPAN; LAPAROSCOPIC SURGERY; LAPAROTOMY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHEDEMA; MEDICAL ASSESSMENT; NORTH AMERICA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PATIENT CARE; PATIENT SELECTION; PELVIS LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SALPINGOOOPHORECTOMY; SLOVAKIA; SMALL INTESTINE OBSTRUCTION; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR VOLUME; UTERUS SURGERY;

CARCINOMA, ENDOMETRIOID; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 34548279411     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(07)70275-9     Document Type: Review

References (81)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Boronow R., Morrow C., Creasman W., et al. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 63 (1984) 825-832
3. Creasman W., Morrow C., Bundy B., Homesley H., Graham J., and Heller P. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60 (1987) 2035-2041
4. Announcements. FIGO stages-1988 Revision. Gynecol Oncol 35 (1989) 125-127
5. Maggino T., Romagnolo C., Landoni F., Sartori E., Zola P., and Gadducci A. An analysis of approaches to the management of endometrial cancer in North America: a CTF study. Gynecol Oncol 68 (1998) 274-279
6. Maggino T., Romagnolo C., Zola P., Sartori E., Landoni F., and Gadducci A. An analysis of approaches to the treatment of endometrial cancer in western Europe: a CTF study. Eur J Cancer 31A (1995) 1993-1997
7. Uharcek P., Mlyncek M., and Ravinger J. Surgical management of endometrial cancer in Slovak Republic. Eur J Surg Oncol 32 (2006) 94-97
8. Kitchener H., Redman C., Swart A., Amos C., and on behalf of ASTEC Study Group. ASTEC. A study in the treatment of endometrial cancer. A randomised trial of lymphadenectomy in the treatment of endometrial cancer. Gynecol Oncol 101 Suppl 1 (2006) S21-S22
9. Aalders J., and Thomas G. Endometrial cancer-revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol 104 (2007) 222-231
10. Creutzberg C., van Putten W., Koper P., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355 (2000) 1404-1411
11. Konno R., Sato S., and Yajima A. A questionnaire survey on current surgical procedures for endometrial cancer in Japan. Tohoku J Exp Med 190 (2000) 193-203
12. Obermair A., Geramou M., Gucer F., et al. Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy. Int J Gynecol Cancer 9 (1999) 383-386
13. Kucera E., Kainz C., Reinthaller A., et al. Accuracy of intraoperative frozen-section diagnosis in stage I endometrial adenocarcinoma. Gynecol Obstet Invest 49 (2000) 62-66
14. Case A., Rocconi R., Straughn Jr. J., et al. A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer. Obstet Gynecol 108 (2006) 1375-1379
15. Mariani A., Webb M., Keeney G., Haddock M., Calori G., and Podratz K. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?. Am J Obstet Gynecol 182 (2000) 1506-1519
16. McMeekin D., Lashbrook D., Gold M., et al. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. Gynecol Oncol 82 (2001) 375-379
17. Reich O., Winter R., Pickel H., Tamussino K., Haas J., and Petru E. Does the size of pelvic lymph nodes predict metastatic involvement in patients with endometrial cancer?. Int J Gynecol Cancer 6 (1996) 445-447
18. Girardi F., Petru E., Heydarfadai M., Haas J., and Winter R. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol 49 (1993) 177-180
19. Horowitz N., Dehdashti F., Herzog T., et al. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol 95 (2004) 546-551
20. Kinkel K., Kaji Y., Yu K., et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212 (1999) 711-718
21. Benedetti-Panici P., Maneschi F., Cutillo G., et al. Anatomical and pathological study of retroperitoneal nodes in endometrial cancer. Int J Gynecol Cancer 8 (1998) 322-327
22. Morrow C., Bundy B., Kurman R., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40 (1991) 55-65
23. Creasman W., Odicino F., Maisonneuve P., et al. Carcinoma of the corpus uteri. Int J Gynaecol Obstet 83 Suppl 1 (2003) 79-118
24. Partridge E., Shingleton H., and Menck H. The National Cancer Data Base report on endometrial cancer. J Surg Oncol 61 (1996) 111-123
25. Aalders J., Abeler V., Kolstad P., and Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56 (1980) 419-427
26. Keys H., Roberts J., Brunetto V., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92 (2004) 744-751
27. Kilgore L., Partridge E., Alvarez R., et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56 (1995) 29-33
28. Mohan D., Samuels M., Selim M., et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 70 (1998) 165-171
29. Cragun J., Havrilesky L., Calingaert B., et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23 (2005) 3668-3675
30. Trimble E., Kosary C., and Park R. Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 71 (1998) 340-343
31. Carey M., O'Connell G., Johanson C., et al. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol 57 (1995) 138-144
32. Eltabbakh G., Piver M., Hempling R., and Shin K. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys 38 (1997) 373-380
33. Chan J., Wu H., Cheung M., Shin J., Osann K., and Kapp D. The outcomes of 27,063 women with unstaged endometriod cancer. Gynecol Oncol 106 (2007) 282-288
34. Chan J., Cheung M., Huh W., et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer 107 (2006) 1823-1830
35. Greer B., Koh W., Abu-Rustum N., et al. Uterine cancers. J Natl Compr Canc Netw 4 (2006) 438-462
36. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 106 (2005) 413-425
37. Mariani A., Webb M., Galli L., and Podratz K. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 76 (2000) 348-356
38. Fanning J. Surgical staging for endometrial cancer. Am J Obstet Gynecol 175 (1996) 513-514
39. Orr Jr. J., Orr P., and Taylor P. Surgical staging endometrial cancer. Clin Obstet Gynecol 39 (1996) 656-668
40. Fanning J., and Firestein S. Prospective evaluation of complete lymphadenectomy in endometiral cancer. Int J Gynecol Cancer 8 (1998) 270-273
41. Gynecologic Oncology Group. Surgical procedures manual (2007). www.gog.org (accessed July 30, 2007).
42. Panici P., Scambia G., Baiocchi G., Matonti G., Capelli A., and Mancuso S. Anatomical study of para-aortic and pelvic lymph nodes in gynecologic malignancies. Obstet Gynecol 79 (1992) 498-502
43. Mariani A., Dowdy S., Cliby W., et al. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol 101 (2006) 200-208
44. Lutman C., Havrilesky L., Cragun J., et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 102 (2006) 92-97
45. Chan J., Urban R., Cheung M., et al. Lymphadenectomy in endometrioid uterine cancer staging. How many lymph nodes are enough? A study of 11,443 patients. Cancer 109 (2007) 2454-2460
46. Goldstein N. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 26 (2002) 179-189
47. Podratz K., Mariani A., and Webb M. Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol Oncol 70 (1998) 163-164
48. Straughn J., Huh W., Orr Jr. J., et al. Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol Oncol 89 (2003) 295-300
49. Orr Jr. J., Roland P., Leichter D., and Orr P. Endometrial cancer: is surgical staging necessary?. Curr Opin Oncol 13 (2001) 408-412
50. Orr Jr. J., Holimon J., and Orr P. Stage I corpus cancer: is teletherapy necessary?. Am J Obstet Gynecol 176 (1997) 777-788
51. Chadha M., Nanavati P., Liu P., Fanning J., and Jacobs A. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 75 (1999) 103-107
52. Ng T., Perrin L., Nicklin J., Cheuk R., and Crandon A. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 79 (2000) 490-494
53. Fanning J. Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. Gynecol Oncol 82 (2001) 371-374
54. Horowitz N., Peters III W., Smith M., Drescher C., Atwood M., and Mate T. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma. Obstet Gynecol 99 (2002) 235-240
55. Solhjem M., Petersen I., and Haddock M. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer. Int J Radiat Oncol Biol Phys 62 (2005) 1379-1384
56. Larson D., and Johnson K. Pelvic and para-aortic lymphadenectomy for surgical staging of high-risk endometrioid adenocarcinoma of the endometrium. Gynecol Oncol 51 (1993) 345-348
57. McMeekin D., Lashbrook D., Gold M., Johnson G., Walker J., and Mannel R. Analysis of FIGO Stage IIIc endometrial cancer patients. Gynecol Oncol 81 (2001) 273-278
58. Onda T., Yoshikawa H., Mizutani K., et al. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer 75 (1997) 1836-1841
59. Larson D., Broste S., and Krawisz B. Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 91 (1998) 355-359
60. Randall M., Filiaci V., Muss H., et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 24 (2006) 36-44
61. Yasunaga M., Yamasaki F., Tokunaga O., and Iwasaka T. Endometrial carcinomas with lymph node involvement: novel histopathologic factors for predicting prognosis. Int J Gynecol Pathol 22 (2003) 341-346
62. Ben-Shachar I., Pavelka J., Cohn D., et al. Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol 105 (2005) 487-493
63. Lo K., Cheung T., Yu M., Yim S., and Chung T. The value of pelvic and para-aortic lymphadenectomy in endometrial cancer to avoid unnecessary radiotherapy. Int J Gynecol Cancer 13 (2003) 863-869
64. Chuang L., Burke T., Tornos C., et al. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol 58 (1995) 189-193
65. Bristow R., Zahurak M., Alexander C., Zellars R., and Montz F. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int J Gynecol Cancer 13 (2003) 664-672
66. Corn B., Lanciano R., Greven K., et al. Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure. Int J Radiat Oncol Biol Phys 24 (1992) 223-227
67. Havrilesky L., Cragun J., Calingaert B., et al. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol 99 (2005) 689-695
68. Abu-Rustum N., Alektiar K., Iasonos A., et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 103 (2006) 714-718
69. Touboul E., Belkacemi Y., Buffat L., et al. Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients. Int J Radiat Oncol Biol Phys 50 (2001) 81-97
70. Corn B., Lanciano R., Greven K., et al. Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. J Clin Oncol 12 (1994) 510-515
71. Querleu D., Leblanc E., Cartron G., Narducci F., Ferron G., and Martel P. Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patients. Am J Obstet Gynecol 195 (2006) 1287-1292
72. Walker J., Piedmonte M., Spirtos N., et al. Surgical staging of uterine cancer: randomized phase III trial of laparoscopy vs laparotomy-a Gynecologic Oncology Group Study (GOG): preliminary results. Proc Am Soc Clin Oncol 24 (2006) (abstr 5010).
73. Mariani A., Keeney G., Aletti G., Webb M., Haddock M., and Podratz K. Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol 92 (2004) 833-838
74. Barnes M., Roland P., Straughn M., Kilgore L., Alvarez R., and Partridge E. A comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact. Gynecol Oncol 74 (1999) 443-447
75. Barakat R., Lev G., Hummer A., Harrah A., and Feldmeier J. Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches. Gynecol Oncol 105 (2007) 150-156
76. Fanning J., Hoffman M., Andrews S., et al. Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation. Gynecol Oncol 93 (2004) 632-636
77. Orr J. Surgical staging of endometrial cancer: does the patient benefit?. Gynecol Oncol 71 (1998) 335-339
78. Burghardt E., and Winter R. The effect of chemotherapy on lymph node metastases in ovarian cancer. Baillieres Clin Obstet Gynaecol 3 (1989) 167-171
79. Baiocchi G., Grosso G., di Re E., Fontanelli R., Raspagliesi F., and di Re F. Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer. Gynecol Oncol 69 (1998) 151-156
80. Chirieac L., Suehiro A., Niemisto I., et al. Size and number of examined lymph nodes impacts outcome in patients with stage II colorectal cancer. Proc Am Soc Clin Oncol 22 abstr 3507 (2004)
81. Carney M., Lancaster J., Ford C., Tsodikov A., and Wiggins C. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?. Gynecol Oncol 84 (2002) 36-42